Tag: Pharmaceuticals

AstraZeneca may buck a decade of pharma strategy to buy U.S. scale

Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge

CVS blows past estimates, hikes guidance as insurance unit continues to improve

Novo Nordisk’s raised forecast fails to change the debate over its obesity business

Pfizer tops estimates, hikes low end of revenue guidance on strength of Eliquis, other drugs

Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal charges

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

Novo Nordisk shares dive after heart medicine fails trial, dealing another blow to its pipeline

New Medicaid work rules could cause patients to lose coverage, rare disease advocates warn

AI stocks rebound, and why J&J’s earnings guidance cut is not cause for concern